Lubani-al-Saleh-Teebi syndrome

Classification according to ICD-10
E84.9	Cystic fibrosis, unspecified
K29.-	Gastritis and duodenitis
ICD-10 online (WHO version 2019)

The Lubani-al-Saleh Teebi syndrome , including cystic fibrosis with Gastritris and megaloblastic is a very rare congenital disease with a combination of Cystic Fibrosis (Cystic fibrosis) with gastritis and megaloblastic anemia .

The name refers to the first authors of the first description from 1991 by the Kuwaiti pediatrician M. M. Lubani and colleagues.

The disease should not be confused with Teebi-al-Saleh-Hassoon syndrome .

distribution

The frequency is given as less than 1 in 1,000,000, the inheritance is autosomal - recessive , the cause is unknown. So far only one family has been reported.

Clinical manifestations

Clinical criteria are: manifestation in infancy with the development of cystic fibrosis, additional gastritis and megaloblastic anemia.

Web links

• Rare Diseases

Individual evidence

1. ↑ ^{a b} Cystic fibrosis with gastritris and megaloblastic anemia. In: Orphanet (Rare Disease Database).
2. ↑ MM Lubani, QA al-Saleh, AS Teebi, A. Moosa, MH Kalaoui: Cystic fibrosis and Helicobacter pylori gastritis, megaloblastic anemia, subnormal mentality and minor anomalies in two siblings: a new syndrome? In: European Journal of Pediatrics. Vol. 150, No. 4, February 1991, pp. 253-255, PMID 2029916 .
3. ↑ CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION.  In: Online Mendelian Inheritance in Man . (English)

This article is about a health issue. It is not used for self-diagnosis and does not replace a diagnosis by a doctor. Please note the information on health issues !